WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsCarlsmed, Inc. Common Stock (CARL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 28748% more annual revenue ($12.91B vs $44.75M). BTSG leads profitability with a 1.5% profit margin vs -57.5%. BTSG earns a higher WallStSmart Score of 54/100 (C-).

BTSG

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 3.0Quality: 7.5
Piotroski: 5/9Altman Z: 2.62

CARL

Avoid

31

out of 100

Grade: F

Growth: 8.0Profit: 3.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BTSGSignificantly Overvalued (-78.4%)

Margin of Safety

-78.4%

Fair Value

$22.46

Current Price

$44.82

$22.36 premium

UndervaluedFair: $22.46Overvalued

Intrinsic value data unavailable for CARL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
29.3%8/10

Revenue surging 29.3% year-over-year

CARL2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
98.4%10/10

Revenue surging 98.4% year-over-year

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Areas to Watch

BTSG4 concerns · Avg: 3.3/10
EPS GrowthGrowth
3.4%4/10

3.4% earnings growth

Return on EquityProfitability
5.9%3/10

ROE of 5.9% — below average capital efficiency

Profit MarginProfitability
1.5%3/10

1.5% margin — thin

Operating MarginProfitability
3.0%3/10

Operating margin of 3.0%

CARL4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$335.19M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-5.81M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.

Bull Case : CARL

The strongest argument for CARL centers on Revenue Growth, Price/Book. Revenue growth of 98.4% demonstrates continued momentum.

Bear Case : BTSG

The primary concerns for BTSG are EPS Growth, Return on Equity, Profit Margin. A P/E of 90.2x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.

Bear Case : CARL

The primary concerns for CARL are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

BTSG profiles as a growth stock while CARL is a hypergrowth play — different risk/reward profiles.

CARL is growing revenue faster at 98.4% — sustainability is the question.

BTSG generates stronger free cash flow (174M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BTSG scores higher overall (54/100 vs 31/100) and 29.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.

Visit Website →

Carlsmed, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.

Want to dig deeper into these stocks?